NSTEMI. Ischemic cardiomyopathy
Conditions
Interventions
Intervention 1: Intervention group: Patients with acute myocardial infarction between the ages of 18 and 85 years, in addition to receiving standard treatment, are treated with coq10 200mg at the time
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Patients with NSTEMI are defined by the World Health Organization by having all three of the following:1- The typical chest pain that lasts more than 20 minutes 2- Failure to raise the ST segment in two adjacent leads 3- Positive cardiac biomarkers such as troponin I or T or CPK-MB 2) Age range from 18 to 85 years 3) Not defining unstable angina and acute myocardial infarction with ST segment ascent for patients
Exclusion criteria
Exclusion criteria: Previous intake of Q10 or other anti-inflammatory drugs during the last month, cardiogenic shock, pulmonary edema level 3 and 4, ventricular arrhythmia including ventricular tachycardia and ventricular fibrillation and atrial fibrillation before the intervention, the existence of AV or SA node block before the intervention or any major complications before the intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Troponin - Cardiac Arrhythmia - Echocardiography Evidence. Timepoint: Before the intervention and 24 hours later for troponin and arrhythma at the time of hospitalization. Method of measurement: hs-troponin Kit and arrythmia based on ecg and hospital monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contact???? ????
Esfahan University of Medical Sciences
Outcome results
None listed